HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome.
|
28017370 |
2017 |
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
|
28017372 |
2017 |
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism.
|
28017373 |
2017 |
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Neurodevelopmental Disorders
|
0.130 |
Biomarker
|
group |
BEFREE |
However, human neurodevelopmental disorders related to EBF3 have not been reported.
|
28017372 |
2017 |
Neurodevelopmental Disorders
|
0.130 |
GeneticVariation
|
group |
BEFREE |
Our findings demonstrate that variants disrupting EBF3-mediated transcriptional regulation cause intellectual disability and developmental delay and are present in ∼0.1% of individuals with unexplained neurodevelopmental disorders.
|
28017373 |
2017 |
Neurodevelopmental Disorders
|
0.130 |
GeneticVariation
|
group |
BEFREE |
Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms.
|
29062322 |
2017 |
Neurodevelopmental Disorders
|
0.130 |
CausalMutation
|
group |
CLINVAR |
|
|
|
Global developmental delay
|
0.120 |
AlteredExpression
|
disease |
BEFREE |
Our findings demonstrate that variants disrupting EBF3-mediated transcriptional regulation cause intellectual disability and developmental delay and are present in ∼0.1% of individuals with unexplained neurodevelopmental disorders.
|
28017373 |
2017 |
Global developmental delay
|
0.120 |
CausalMutation
|
disease |
CLINVAR |
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
|
28017372 |
2017 |
Global developmental delay
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms.
|
29062322 |
2017 |
Global developmental delay
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Ataxia
|
0.110 |
CausalMutation
|
phenotype |
CLINVAR |
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
|
28017372 |
2017 |
Ataxia
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms.
|
29062322 |
2017 |
Cerebellar Ataxia
|
0.110 |
CausalMutation
|
phenotype |
CLINVAR |
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
|
28017372 |
2017 |
Cerebellar Ataxia
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms.
|
29062322 |
2017 |
Strabismus
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms.
|
29062322 |
2017 |
Strabismus
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.
|
28017372 |
2017 |
Intellectual Disability
|
0.110 |
AlteredExpression
|
group |
BEFREE |
Our findings demonstrate that variants disrupting EBF3-mediated transcriptional regulation cause intellectual disability and developmental delay and are present in ∼0.1% of individuals with unexplained neurodevelopmental disorders.
|
28017373 |
2017 |
Strabismus
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Intellectual Disability
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|